Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPERT: Exemestane in Ovarian Cancer
NCT04460807Phase 3Terminated
- Sponsor
- Ospedali Galliera
- Start
- Feb 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in epithelial ovarian cancer (EOC), sponsored by Ospedali Galliera. Started Feb 2020; status: terminated.
02
Drugs
exemestane
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT04460807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460807.